Ads
related to: adrenergic agonist for obesity
Search results
Results From The WOW.Com Content Network
The β 3 (beta 3) adrenergic receptor agonist or β 3-adrenoceptor agonist, also known as β 3-AR agonist, are a class of medicine that bind selectively to β 3-adrenergic receptors. β 3 -AR agonists for the treatment of obesity and type 2 diabetes have been in developmental stages within many large pharmaceutical companies since the early ...
[18] [19] The anti-obesity effects of amphetamines, besides acting on the brain to reduce energy intake, are also mediated by the beta-2 adrenergic receptor. [20] [17] Ephedrine (and related compounds that are also active ingredients in ephedra preparations) exert their effects by acting directly and indirectly as adrenergic agonists. [21]
The mechanisms of sympathomimetic drugs can be direct-acting (direct interaction between drug and receptor), such as α-adrenergic agonists, β-adrenergic agonists, and dopaminergic agonists; or indirect-acting (interaction not between drug and receptor), such as MAOIs, COMT inhibitors, release stimulants, and reuptake inhibitors that increase the levels of endogenous catecholamines.
155 11556 Ensembl ENSG00000188778 ENSMUSG00000031489 UniProt P13945 P25962 RefSeq (mRNA) NM_000025 NM_013462 RefSeq (protein) NP_000016 NP_038490 Location (UCSC) Chr 8: 37.96 – 37.97 Mb Chr 8: 27.23 – 27.25 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse The beta-3 adrenergic receptor (β 3 -adrenoceptor), also known as ADRB3, is a beta-adrenergic receptor, and also denotes the ...
Medicaid beneficiaries in North Carolina will soon be able to get GLP-1 drugs like Wegovy, Saxenda and Zepbound covered.
GLP-1 receptor agonists (35 P) W. Withdrawn anti-obesity drugs (9 P) Pages in category "Anti-obesity drugs" The following 21 pages are in this category, out of 21 total.